Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide

The neural membranes contain phospholipids, sphingolipids, cholesterol, and proteins. Glycerophospholipids and sphingolipids are precursors for lipid mediators involved in signal transduction processes. Degradation of glycerophospholipids by phospholipase A2 (PLA2) generates arachidonic acid (AA) and docosahexaenoic acids (DHA). Arachidonic acid is metabolized to eicosanoids and DHA is metabolized to docosanoids. The catabolism of glycosphingolipids generates ceramide, ceramide 1‐phosphate, sphingosine, and sphingosine 1‐phosphate. These metabolites modulate PLA2 activity. Arachidonic acid, a product derived from glycerophospholipid catabolism by PLA2, modulates sphingomyelinase (SMase), the enzyme that generates ceramide and phosphocholine. Furthermore, sphingosine 1‐phosphate modulates cyclooxygenase, an enzyme responsible for eicosanoid production in brain. This suggests that an interplay and cross talk occurs between lipid mediators of glycerophospholipid and glycosphingolipid metabolism in brain tissue. This interplay between metabolites of glycerophospholipid and sphingolipid metabolism may play an important role in initiation and maintenance of oxidative stress associated with neurologic disorders as well as in neural cell proliferation, differentiation, and apoptosis. Recent studies indicate that PLA2 and SMase inhibitors can be used as neuroprotective and anti‐apoptotic agents. Development of novel inhibitors of PLA2 and SMase may be useful for the treatment of oxidative stress, and apoptosis associated with neurologic disorders such as stroke, Alzheimer disease, Parkinson disease, and head and spinal cord injuries. © 2007 Wiley‐Liss, Inc.

[1]  C. Serhan Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins , 2005, Current opinion in clinical nutrition and metabolic care.

[2]  D. Selkoe,et al.  Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain , 1996, Neurobiology of Disease.

[3]  Hiroyuki Nakamura,et al.  Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. , 2004, European journal of pharmacology.

[4]  E. Costa,et al.  N‐Methyl‐d‐Aspartate‐Sensitive Glutamate Receptors Induce Calcium‐Mediated Arachidonic Acid Release in Primary Cultures of Cerebellar Granule Cells , 1990, Journal of neurochemistry.

[5]  P. Sastry,et al.  Apoptosis and the Nervous System , 2000, Journal of neurochemistry.

[6]  D. Adam,et al.  Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor , 1998, Journal of leukocyte biology.

[7]  G. Poirier,et al.  Modulation of caspase-3 activity by zinc ions and by the cell redox state. , 2001, Experimental cell research.

[8]  M. Mattson,et al.  Arachidonic Acid‐Induced Oxidative Injury to Cultured Spinal Cord Neurons , 1999, Journal of neurochemistry.

[9]  C. Leslie,et al.  Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2* , 2004, Journal of Biological Chemistry.

[10]  D. Wallach,et al.  Cell death induction by TNF: a matter of self control. , 1997, Trends in biochemical sciences.

[11]  E. Shooter,et al.  The Neurotrophin Receptor p75NTR as a Positive Modulator of Myelination , 2002, Science.

[12]  Kiyoko Fukami,et al.  Structure, regulation, and function of phospholipase C isozymes. , 2002, Journal of biochemistry.

[13]  Francesca Bosetti,et al.  Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain , 2004, Biological Psychiatry.

[14]  R. Dempsey,et al.  Citicoline: neuroprotective mechanisms 
in cerebral ischemia , 2002, Journal of neurochemistry.

[15]  T. Parmley,et al.  Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys. , 1982, Fertility and sterility.

[16]  L. Miele New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase. , 2003, The Journal of clinical investigation.

[17]  J. Pettegrew,et al.  Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia , 1995, Neurobiology of Aging.

[18]  G. Porcellati Phospholipid Metabolism in Neural Membranes , 1983 .

[19]  L. Horrocks,et al.  Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury , 2002 .

[20]  H. de Groot,et al.  2n-fatty acids from phosphatidylcholine label sphingolipids--a novel role of phospholipase A2? , 2005, Biochimica et biophysica acta.

[21]  H. Umehara,et al.  Increase of Nuclear Ceramide through Caspase-3-Dependent Regulation of the “Sphingomyelin Cycle” in Fas-Induced Apoptosis , 2004, Cancer Research.

[22]  Michael C. J. Chang,et al.  Chronic Lithium Treatment Decreases Brain Phospholipase A2 Activity , 1998, Neurochemical Research.

[23]  R. Schnellmann,et al.  Phospholipase A(2)s in cell injury and death. , 2000, The Journal of pharmacology and experimental therapeutics.

[24]  Haseeb Ahmad Khan,et al.  Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents , 2001, Brain Research Bulletin.

[25]  S. Milstien,et al.  Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells , 2001, Journal of neurochemistry.

[26]  N. Bazan Lipid signaling in neural plasticity, brain repair, and neuroprotection , 2005, Molecular Neurobiology.

[27]  Y. Hannun,et al.  Ceramide: an intracellular signal for apoptosis. , 1995, Trends in biochemical sciences.

[28]  Shailendra Giri,et al.  Peroxisomal participation in psychosine‐mediated toxicity: Implications for Krabbe's disease , 2005, Journal of neuroscience research.

[29]  A. Bielawska,et al.  Ceramide Kinase Mediates Cytokine- and Calcium Ionophore-induced Arachidonic Acid Release* , 2003, Journal of Biological Chemistry.

[30]  C. Lindsley,et al.  The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation. , 2005, Current topics in medicinal chemistry.

[31]  A. Yakovlev,et al.  Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. , 2002, Biochemical and biophysical research communications.

[32]  D. Stephenson,et al.  Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration , 1999, Glia.

[33]  Y. Tsuji,et al.  Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress , 2004, Neurochemistry International.

[34]  Y. Hannun,et al.  Bioactive sphingolipids in the modulation of the inflammatory response. , 2006, Pharmacology & therapeutics.

[35]  L. Horrocks,et al.  Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders , 1999, Brain Research Bulletin.

[36]  Y. Hannun,et al.  Phospholipase A2 Is Necessary for Tumor Necrosis Factor α-induced Ceramide Generation in L929 Cells* , 1997, The Journal of Biological Chemistry.

[37]  B. Kriem,et al.  Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway , 2006, Neurobiology of Disease.

[38]  Chung Y. Hsu,et al.  Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain , 2004, Journal of neurochemistry.

[39]  S. Rapoport,et al.  Energy Consumption by Phospholipid Metabolism in Mammalian Brain , 2002, Neurochemical Research.

[40]  D. A. Foster,et al.  Role for Phospholipase D in Receptor-Mediated Endocytosis , 2001, Molecular and Cellular Biology.

[41]  M. Tsujimoto,et al.  Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. , 1996, Biochemical and biophysical research communications.

[42]  D. Souza,et al.  Neurotoxicity Induced by Glutamate in Glucose-Deprived Rat Hippocampal Slices is Prevented by GMP , 2004, Neurochemical Research.

[43]  L. Horrocks,et al.  Comprar Glycerophospholipids in the Brain · Phospholipases A2 in Neurological Disorders | Farooqui, Akhlaq A. | 9780387366029 | Springer , 2007 .

[44]  S. Rapoport,et al.  Imaging of brain serotonergic neurotransmission involving phospholipase A2 activation and arachidonic acid release in unanesthetized rats. , 2003, Brain research. Brain research protocols.

[45]  Victoria Magrioti and George Kokotos Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2 , 2006 .

[46]  Xianlin Han,et al.  Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway , 2004, The Journal of Cell Biology.

[47]  S. Rapoport,et al.  The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways , 2004, Brain Research Bulletin.

[48]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[49]  L. Horrocks,et al.  Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[50]  B. Halliwell,et al.  Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices. , 2001, Free radical biology & medicine.

[51]  T. Liu,et al.  Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. , 2001, Life sciences.

[52]  V. Mamidipudi,et al.  Dual role for p75NTR signaling in survival and cell death: Can intracellular mediators provide an explanation? , 2002, Journal of neuroscience research.

[53]  M. Krönke,et al.  TNF Receptor Death Domain-associated Proteins TRADD and FADD Signal Activation of Acid Sphingomyelinase* , 1998, The Journal of Biological Chemistry.

[54]  L. Horrocks,et al.  Stimulation of Lipases and Phospholipases in Alzheimer Disease , 2003 .

[55]  S. Rapoport,et al.  85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. , 1999, Neuroreport.

[56]  Y. Hannun,et al.  The extended family of neutral sphingomyelinases. , 2006, Biochemistry.

[57]  G. Barrett The p75 neurotrophin receptor and neuronal apoptosis , 2000, Progress in Neurobiology.

[58]  L. Horrocks,et al.  Arachidonic Acid, Neurotrauma, and Neurodegenerative Diseases , 1997 .

[59]  G. Melino,et al.  Lipoxygenases and their involvement in programmed cell death , 2001, Cell Death and Differentiation.

[60]  N. Ridgway,et al.  Molecular mechanisms and regulation of ceramide transport. , 2005, Biochimica et biophysica acta.

[61]  I. Akiguchi,et al.  Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia , 2004, Brain Research.

[62]  Y. Banno Regulation and possible role of mammalian phospholipase D in cellular functions. , 2002, Journal of biochemistry.

[63]  Y. Nomura,et al.  Possible involvement of cytosolic phospholipase A2 in cell death induced by 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in GH3 cells , 2000, Brain Research.

[64]  L. Horrocks,et al.  Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders , 2006, Pharmacological Reviews.

[65]  F. Tremblay,et al.  Sphingosine 1‐phosphate effect on endothelial cell PAF synthesis: Role in cellular migration , 2003, Journal of cellular biochemistry.

[66]  J. Phillis,et al.  The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion , 1997, Brain Research.

[67]  J. Phillis,et al.  Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders , 2006, Brain Research Reviews.

[68]  Shailendra Giri,et al.  Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death Published, JLR Papers in Press, April 27, 2006. , 2006, Journal of Lipid Research.

[69]  S. Wassall,et al.  Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.

[70]  Yusuf A. Hannun,et al.  The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.

[71]  S. Kohsaka,et al.  Ceramide activates microglia to enhance the production/secretion of brain‐derived neurotrophic factor (BDNF) without induction of deleterious factors in vitro , 2002, Journal of neurochemistry.

[72]  A. Kihara,et al.  Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes. , 2006, Biological & pharmaceutical bulletin.

[73]  C. Masters,et al.  Involvement of the 5‐lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106‐126 , 2001, Journal of neuroscience research.

[74]  L. Horrocks,et al.  Choline and Ethanolamine Glycerophospholipids , 2009 .

[75]  R. Cunha,et al.  Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus , 1999, Brain Research.

[76]  P. Codogno,et al.  Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells , 2002, Biological chemistry.

[77]  Philippe P Roux,et al.  Neurotrophin signaling through the p75 neurotrophin receptor , 2002, Progress in Neurobiology.

[78]  J. Engelhardt,et al.  Subcellular site of superoxide dismutase expression differentially controls AP‐1 activity and injury in mouse liver following ischemia/reperfusion , 2001, Hepatology.

[79]  M. Westphal,et al.  Cyclo-Oxygenase Inhibitors and Thromboxane Synthase Inhibitors Differentially Regulate Migration Arrest, Growth Inhibition and Apoptosis in Human Glioma Cells , 2002, Acta Neurochirurgica.

[80]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[81]  R. Kolesnick,et al.  Signal transduction of stress via ceramide. , 1998, The Biochemical journal.

[82]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[83]  S. Okuda,et al.  Arachidonic acid as a neurotoxic and neurotrophic substance , 1995, Progress in Neurobiology.

[84]  G. Dbaibo,et al.  Hippocampal Programmed Cell Death after Status Epilepticus: Evidence for NMDA‐Receptor and Ceramide‐Mediated Mechanisms , 2003, Epilepsia.

[85]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Michael Cascio,et al.  Effects of membrane lipids on ion channel structure and function , 2007, Cell Biochemistry and Biophysics.

[87]  L. Horrocks,et al.  Deacylation and reacylation of neural membrane glycerophospholipids , 2000, Journal of Molecular Neuroscience.

[88]  G. Jenkins,et al.  Phospholipase D: a lipid centric review , 2005, Cellular and Molecular Life Sciences CMLS.

[89]  Y. Hannun,et al.  Sphingolipids in inflammation: roles and implications. , 2004, Current molecular medicine.

[90]  A. Bielawska,et al.  Ceramide 1-Phosphate Acts as a Positive Allosteric Activator of Group IVA Cytosolic Phospholipase A2α and Enhances the Interaction of the Enzyme with Phosphatidylcholine* , 2005, Journal of Biological Chemistry.

[91]  N. Nishiyama,et al.  Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability , 2001, The European journal of neuroscience.

[92]  A. Ogura,et al.  Nerve Growth Factor-induced Glutamate Release Is via p75 Receptor, Ceramide, and Ca2+ from Ryanodine Receptor in Developing Cerebellar Neurons* , 2003, Journal of Biological Chemistry.

[93]  A. Guilherme,et al.  Sphingosine-1-phosphate formation activates phosphatidylinositol-4 kinase in basolateral membranes from kidney cells: crosstalk in cell signaling through sphingolipids and phospholipids. , 2003, Journal of biochemistry.

[94]  B. S. Robinson,et al.  Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated‘qc fatty acids , 1997, Immunology.

[95]  S. Kuroda,et al.  FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release , 2004, Brain Research.

[96]  R. Catalán,et al.  Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. , 2003, European journal of biochemistry.

[97]  Gary E. Gibson,et al.  Brain energetics, integration of molecular and cellular processes , 2007 .

[98]  J. Koizumi,et al.  Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity. , 2003, Bioorganic & medicinal chemistry letters.

[99]  S. Milstien,et al.  Ceramide‐induced cell death in primary neuronal cultures: Upregulation of ceramide levels during neuronal apoptosis , 2002, Journal of neuroscience research.

[100]  L. Horrocks,et al.  Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. , 2005, Reproduction, nutrition, development.

[101]  L. Horrocks,et al.  Identification and Purification of Calcium‐Independent Phospholipase A2 from Bovine Brain Cytosol , 1992, Journal of neurochemistry.

[102]  M. Mattson,et al.  Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis , 2000, Journal of Molecular Neuroscience.

[103]  E. Korkotian,et al.  Elevation of Intracellular Glucosylceramide Levels Results in an Increase in Endoplasmic Reticulum Density and in Functional Calcium Stores in Cultured Neurons* , 1999, The Journal of Biological Chemistry.

[104]  Charles N. Serhan,et al.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.

[105]  L. Horrocks,et al.  Excitotoxicity and neurological disorders: involvement of membrane phospholipids. , 1994, International review of neurobiology.

[106]  N. Bazan Neuroprotectin D1 (NPD1): A DHA‐Derived Mediator that Protects Brain and Retina Against Cell Injury‐Induced Oxidative Stress , 2005, Brain pathology.

[107]  S. Manna,et al.  Bcl-xL Suppresses TNF-Mediated Apoptosis and Activation of Nuclear Factor-κB, Activation Protein-1, and c-Jun N-Terminal Kinase , 2000 .

[108]  Susan Betito,et al.  Ceramide in Apoptosis: A Revisited Role , 2002, Neurochemical Research.

[109]  L. Horrocks,et al.  Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration. , 2004, Current drug targets. Cardiovascular & haematological disorders.

[110]  Y. Hannun,et al.  Acid and neutral sphingomyelinases: roles and mechanisms of regulation. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[111]  D. Murphy,et al.  5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter , 2005, Psychopharmacology.

[112]  M. Balboa,et al.  Bromoenol Lactone Promotes Cell Death by a Mechanism Involving Phosphatidate Phosphohydrolase-1 Rather than Calcium-independent Phospholipase A2* , 2003, Journal of Biological Chemistry.

[113]  Sphingolipid Metabolism and Signaling Minireview Series* , 2002, The Journal of Biological Chemistry.

[114]  D. MacEwan Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis , 1996, FEBS letters.

[115]  A. Colquhoun Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells , 1998, Biochemistry and molecular biology international.

[116]  Teruo Hayashi,et al.  Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release* , 2006, Journal of Biological Chemistry.

[117]  Y. Hannun,et al.  The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate , 2005, Molecular Pharmacology.

[118]  K. Yasuda,et al.  Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes. , 2003, Metabolism: clinical and experimental.

[119]  B. Monia,et al.  Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. , 2001, Molecular pharmacology.

[120]  S. Orrenius,et al.  Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells , 1997, Cell Death and Differentiation.

[121]  L. Horrocks,et al.  Modulation of inflammation in brain: a matter of fat , 2006, Journal of neurochemistry.

[122]  K. Takeuchi,et al.  Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. , 1993, The Journal of biological chemistry.

[123]  M. Song,et al.  Inhibition of rat sympathetic neuron apoptosis by ceramide. Role of p75NTR in ceramide generation , 2003, Neuropharmacology.

[124]  R. Raghow,et al.  Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. , 1992, The Journal of biological chemistry.

[125]  A. Nicolini,et al.  Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis , 2003, Journal of neurochemistry.

[126]  M. Matsumoto,et al.  [Phospholipase D]. , 1986, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[127]  L. Horrocks,et al.  Plasmalogens, docosahexaenoic acid and neurological disorders. , 2003, Advances in experimental medicine and biology.

[128]  B. Stoica,et al.  Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins , 2005, Molecular and Cellular Neuroscience.

[129]  A. Schapira,et al.  Oxidative stress and mitochondrial dysfunction in neurodegeneration , 1996, Current opinion in neurology.

[130]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[131]  J. Phillis,et al.  A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders , 2004, Brain Research Reviews.

[132]  M. Tsujimoto,et al.  Asymmetric distribution of phospholipids in biomembranes. , 2006, Biological & pharmaceutical bulletin.

[133]  I. Herr,et al.  FK506 prevents stroke-induced generation of ceramide and apoptosis signaling , 1999, Brain Research.

[134]  Takao Shimizu,et al.  Stimulation of erythrocyte ceramide formation by platelet-activating factor , 2005, Journal of Cell Science.

[135]  L. Horrocks,et al.  Biochemical Aspects of Neurodegeneration in Human Brain: Involvement of Neural Membrane Phospholipids and Phospholipases A2 , 2004, Neurochemical Research.

[136]  C. Serhan Novel omega -- 3-derived local mediators in anti-inflammation and resolution. , 2005, Pharmacology & therapeutics.

[137]  J. Arevalo,et al.  Neurotrophin signaling: many exciting surprises! , 2006, Cellular and Molecular Life Sciences CMLS.

[138]  L. Horrocks,et al.  Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .

[139]  Carola Hunte,et al.  Lipids in membrane protein structures. , 2004, Biochimica et biophysica acta.

[140]  A. Kihara,et al.  Cross talk between sphingolipids and glycerophospholipids in the establishment of plasma membrane asymmetry. , 2004, Molecular biology of the cell.

[141]  L. Horrocks,et al.  Brain phospholipases and their role in signal transduction. , 1992, Advances in experimental medicine and biology.

[142]  R. Dempsey,et al.  Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. , 2003, Antioxidants & redox signaling.

[143]  T. Kobori,et al.  Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase. , 2003, Bioorganic & medicinal chemistry letters.

[144]  J. Ohanian,et al.  Sphingolipids in mammalian cell signalling , 2001, Cellular and Molecular Life Sciences CMLS.

[145]  A. Gomez-Muñoz Modulation of cell signalling by ceramides. , 1998, Biochimica et biophysica acta.

[146]  J. Exton,et al.  Purification and properties of phospholipase A1 from bovine brain. , 1994, The Journal of biological chemistry.

[147]  R. Malaviya,et al.  Targeting cytosolic phospholipase A2 by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice. , 2006, European journal of pharmacology.

[148]  L. Horrocks,et al.  Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. , 2000, Chemistry and physics of lipids.

[149]  R. Yu,et al.  Regulation of Apoptosis during Neuronal Differentiation by Ceramide and b-Series Complex Gangliosides* , 2001, The Journal of Biological Chemistry.

[150]  L. Horrocks,et al.  Brain phospholipases A2: a perspective on the history. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[151]  J. Axelrod Phospholipase A2 and G proteins , 1995, Trends in Neurosciences.

[152]  Elizabeth R. Smith,et al.  Differential Roles of de Novo Sphingolipid Biosynthesis and Turnover in the "Burst" of Free Sphingosine and Sphinganine, and Their 1-Phosphates and N-Acyl-Derivatives, That Occurs upon Changing the Medium of Cells in Culture (*) , 1995, The Journal of Biological Chemistry.

[153]  Song‐Pyo Hong,et al.  Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[154]  J. Axelrod,et al.  Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. , 1990, Biochemical Society transactions.

[155]  S. Rapoport,et al.  Energy requirements for two aspects of phospholipid metabolism in mammalian brain. , 1998, The Biochemical journal.

[156]  Y. Hannun,et al.  Ceramide Regulation of Apoptosis versus Differentiation: A Walk on a Fine Line. Lessons from Neurobiology , 2002, Neurochemical Research.